New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics
Welcome to the August 2016 issue of PharmSource PERISCOPE
This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.
Enjoy the August issue!
PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity
|Lead Type||July 2016||YTD 2016|
|Total Drug Leads||380||2612|
|Total Device &
*Total leads include acquisitions/alliances, company acquisition/alliances and events.
Aurinia Pharmaceuticals Inc. plans to initiate a Phase III program in 2017 with Voclosporin, a novel immunomodulating calcineurin inhibitor, for the treatment of lupus nephritis:
- Therapeutic Area: Urology, Immunomodulator
- Dosage Form: Capsule – Hard shell
- API: Chemical – Normal potency
Get deeper information about the likely upcoming needs of Aurinia, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.
Territory Watch: Look Beyond the Usual to Capture New Business
by Katie Ludwick, Marketing Manager
The majority of bio/pharma funding events in the U.S. during 2014 and 2015 occurred outside the high-profile hubs of the San Francisco Bay Area and Boston. However, CROs and CDMOs looking to capture new business will find substantial opportunities in geographically concentrated areas far beyond those more prominent regions.
Business opportunities based on new bio/pharma company financings in geographically compact areas outside the most high-profile venues are truly significant. CROs and CDMOs can strategically focus sales resources in… read on
Follow the Money to
Medical Device & Diagnostic Opportunities
Spotlight on Avita Medical Ltd.
Avita Medical is a public company based in the United Kingdom that develops regenerative and tissue-engineered products to treat a broad range of wounds, scars and skin defects. They raised $9 million in a completion of a secondary public offering.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support US commercialization of their pipeline, such as… read on
Follow the Money to
Spotlight on Galena Biopharma, Inc.
Galena Biopharma is a U.S. public biopharmaceutical company that develops targeted oncology treatments to address unmet medical needs that advance cancer care. They raised $12.6 million in a secondary public offering.
What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support clinical trials of their pipeline, possibly including… read on
PharmSource Summer Reading: Blog Briefs
As summer winds down, we thought you might be interested in some useful light reading before the autumn craziness begins.
We’ve looked over our blog for some articles we think will be of particular interest to you and your team:
- Slower Bio/Pharma Investment Could Hurt CDMOs in 2017
- Vetter to Build US Commercial Facility
- Global Bio/pharma Continues to Spend on PP&E
We hope you enjoy the rest of your summer and find these articles useful.
PharmSource President Jim Miller to Speak at Industry Event
Contract Pharma: 15th Annual Conference and Tabletop Exhibition.
New Brunswick, New Jersey
Thursday, September 22 at 1:30 pm
Celebrating 20 Years in Business!
Thank you to our clients, colleagues and friends. We look forward to many more years of successful business together.
PharmSource Lead Sheet
The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.
Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.
See for yourself how this resource can be a vital tool for building your brand and growing your market share.
To request a test-drive today, contact Nathaniel Celentano at firstname.lastname@example.org / 1-703-383-4903, ext. 112 (ET USA).